HopeStage
Back to all studies
CompletedNCT00816894

D-serine or olanzapine for schizophrenia

About this titleRead the official source — NCT00816894

Researchers compared D-serine and Olanzapine to find out how the approaches affected psychotic symptoms in people with schizophrenia.

Medication studyAges 18–70Israel
The study in practice

Understand this study

What did researchers investigate?

Researchers compared D-serine and Olanzapine to find out how the approaches affected psychotic symptoms in people with schizophrenia.

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
JerusalemSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2009
Recruitment status
Completed
Enrollment listed in the registry
18
Sponsor
Herzog Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Israel
Age range
From 18 Years to 70 Years
Official registry ID
NCT00816894
Official title
Show the full official title

D-serine Antipsychotic Monotherapy for Treatment Refractory Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Jerusalem

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared D-serine and Olanzapine to find out how the approaches affected psychotic symptoms in people with schizophrenia.

Who is behind this study?

The study sponsor is Herzog Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including D-serine and Olanzapine.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies